Monthly Archives: April 2013

A Defacto Placebo Effect?

After reading the Greenslit piece, I wonder if the way a drug gets packaged can influence that drug’s efficacy. I.e., might there be a placebo effect from taking a drug with certain “inessential” characteristics versus taking a chemically identical drug … Continue reading

Posted in Uncategorized | Leave a comment

The business of rebranding

In Nathan Greenslits’ article “Depression and consumption: Psychopharmaceuticals, Branding, and New Identity Practices”, he focuses on how our ideas about mental health are produced by pharmaceutical companies and are inevitably consumed by the public. Throughout the article, he uses the … Continue reading

Posted in Uncategorized | Leave a comment

Prozac & Sarafe- Identical but different

  Nathan Greenslit’s “Depression and Consumption: Psychopharmaceuticals, Branding, and New Identity Practices” examines a case where two chemically identical pharmaceutical drugs are branded and marketed as different, serving different purposes.  Fluoxetine Hydrochloride, under the brand name Prozac is marketed as … Continue reading

Posted in Uncategorized | 1 Comment

The New (Improved..?) Roles of Drugs

Greenslit’s article raises interesting questions about the ways both institutions and individuals appropriate drugs for their own use and to achieve a variety of ends. In their growing new role as consumer products, it seems to some extent unavoidable that … Continue reading

Posted in Uncategorized | Leave a comment

Both Hayden “Pharmaceuticals and the Politics of the Similar in Mexico” and Greenslit’s “Depression and Consumption” partly address how drug prescriptions give primacy to brand names over active substances. Hayden reports how in 1998 the Ministry of Health in Mexico … Continue reading

Aside | Posted on by | Leave a comment

Greenslit article comment

Nathan Greenslit challenges us to think about our relationships with pharmaceuticals. I didn’t think the article was just about consumption and branding, but rather identity practices that place the reader/consumer in a state of being. This state of being may … Continue reading

Posted in Uncategorized | Leave a comment

The Social Identification and Integration of Pharmaceutical Products

In ‘Depression and Consumption: Psychopharmaceuticals, Branding, and New Identity Practices,’ Nathan Greenslit suggests that the packaging, marketing and targeting of pharmaceutical products not only allows them to assume changing social lives, but allows them to represent various cultural messages that … Continue reading

Posted in Uncategorized | Leave a comment